EUVIMEDEUVIMED entdecken
Open Access

Nuclear TOP1MT Confers Cisplatin Resistance via Pseudogene in HNSCC

T Tong, P S Zhai, X Qin, Z Zhang, C W Li, H Y Guo, H L Ma iD

Journal of Dental Research · 2024

DOI: 10.1177/00220345241272017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Dental Research, 2024. Verfasst von T Tong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head & Neck Oncology, Shanghai Ninth People's Hospital. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Pseudogenes, DNA Topoisomerases, Type I. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Hospital Level Foundation of Shanghai Stomatological Hospital, Science and Technology Daystar Program of Shanghai, Young physicians collaborative innovation team of Shanghai Ninth People’s Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin resistance is one of the major causes of treatment failure in head and neck squamous cell carcinoma (HNSCC). There is an urgent need to uncover the underlying mechanism for developing effective treatment strategies. A quantitative proteomics assay was used to identify differential proteins in cisplatin-resistant cells. Mitochondrial topoisomerase I (TOP1MT) localization was determined using laser confocal microscopy and nucleocytoplasmic separation assay. Chromatin immunoprecipitation sequencing, dual-luciferase reporter assay, and RNA immunoprecipitation were used to identify the interaction between pseudogenes, miRNAs, and real genes. In vivo experiments verified the interaction between TOP1MT and pseudogenes on cisplatin resistance. TOP1MT was identified as a driving factor of cisplatin resistance in vitro, in vivo, and in HNSCC patients. Moreover, TOP1MT exceptionally translocated to the nucleus in cisplatin-resistant HNSCC cells in a signal peptide–dependent manner. Nuclear TOP1MT (nTOP1MT) transcriptionally regulated the mitochondrial functional pseudogene MTATP6P1, which bound to miR-137 and miR-491-5p as a competing endogenous RNA (ceRNA) and promoted the expression of MTATP6. An increase in MTATP6 enhanced mitochondrial oxidative phosphorylation (OXPHOS), which conferred cisplatin resistance in HNSCC. Our findings revealed that nTOP1MT transcriptionally activated MTAPT6P1 and increased MTATP6 expression via ceRNA, which facilitated OXPHOS and cisplatin resistance. These results provide novel insight for overcoming cisplatin resistance in HNSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinDrug Resistance, NeoplasmPseudogenesDNA Topoisomerases, Type IHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckHumansCell Line, TumorCarcinoma, Squamous CellAntineoplastic AgentsMitochondriaMiceCell NucleusAnimalsMicroRNAsMicroscopy, Confocal

Stichwörter der Autor:innen

adjuvant chemotherapyhead and neck cancermiRNAnuclear localization signal peptideoxidative phosphorylationpseudogenes

Substanzen

CisplatinDNA Topoisomerases, Type IAntineoplastic AgentsMicroRNAs

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial-Head & Neck Oncology, Shanghai Ninth People's Hospital.
  • Shanghai Jiao Tong University School of Medicine, PR China.
  • College of Stomatology, Shanghai Jiao Tong University, PR China.
  • National Center for Stomatology, PR China.
  • National Clinical Research Center for Oral Diseases, PR China.
  • Shanghai Key Laboratory of Stomatology, Shanghai, PR China.

ORCID-Profile: H L Ma

Förderung

  • Hospital Level Foundation of Shanghai Stomatological Hospital
  • Science and Technology Daystar Program of Shanghai
  • Young physicians collaborative innovation team of Shanghai Ninth People’s Hospital
  • National Natural Science Foundation of China
  • The Innovative Research Team of High-level Local Universities in Shanghai
  • Young Talent Lift Project by the China Association for Science and Technology

Zitieren

APA

Tong, T., Zhai, P. S., Qin, X., Zhang, Z., Li, C. W., Guo, H. Y., & Ma, H. L. (2024). Nuclear TOP1MT Confers Cisplatin Resistance via Pseudogene in HNSCC. Journal of Dental Research. https://doi.org/10.1177/00220345241272017

Vancouver

Tong T, Zhai PS, Qin X, Zhang Z, Li CW, Guo HY, et al. Nuclear TOP1MT Confers Cisplatin Resistance via Pseudogene in HNSCC. Journal of Dental Research. 2024. doi:10.1177/00220345241272017

BibTeX
@article{Tong2024,
  author = {Tong, T and Zhai, P S and Qin, X and Zhang, Z and Li, C W and Guo, H Y and Ma, H L},
  title = {Nuclear TOP1MT Confers Cisplatin Resistance via Pseudogene in HNSCC},
  journal = {Journal of Dental Research},
  year = {2024},
  doi = {10.1177/00220345241272017}
}
Kostenlos starten →